Keyphrases
Heart Failure
77%
Pathophysiological Mechanisms
37%
Doxorubicin-induced Cardiotoxicity
34%
Selenium Deficiency
31%
Low Selenium
30%
Serum Selenium
26%
Patients with Heart Failure
24%
BIOSTAT-CHF
24%
Doxorubicin
21%
Heart Disease
21%
Pathophysiology
21%
Senescence
20%
Mitochondrial Dysfunction
17%
Aging Phenotype
17%
Plasminogen Activator inhibitor-1 (PAI-1)
17%
Shared Environment
17%
Phospholamban
17%
New Biomarkers
17%
Micronutrient Deficiency
17%
Accelerated Aging
17%
Translational Approach
17%
Metabolomics Data
17%
Clinical Tool
17%
IL-17D
17%
Precision Medicine
17%
Peripartum Cardiomyopathy
17%
Muscarinic Receptors
17%
Low Serum
17%
Sexual Dimorphism
17%
Beneficial Properties
17%
Metabolic Syndrome
17%
Aging
17%
Dynamic Loading
17%
Worsening Heart Failure
17%
Autoantibodies
17%
Micronutrients
17%
Family Resemblance
17%
Inherited Cardiomyopathy
17%
Cathepsin D
17%
Binding Protein
17%
Insulin-like
17%
Incident Heart Failure
17%
End-organ Disease
17%
Growth Factor Binding
17%
Longitudinal Change
17%
Failure Data
17%
Mortality Prediction
17%
NMR Metabolomics
17%
DNA Methylation (DNAm)
17%
Selenium
15%
Biochemistry, Genetics and Molecular Biology
Cardiac Muscle Cell
77%
Selenium Blood Level
67%
Metabolomics
53%
Metabolite
49%
Genetics
30%
Selenium Deficiency
30%
Induced Pluripotent Stem Cell
24%
C-Reactive Protein
24%
Stem Cell
24%
Disease Modeling
23%
Iron Deficiency
22%
Lipid
20%
Selenoprotein
20%
Prevalence
19%
Atrial Fibrillation
19%
Sex Difference
17%
Oligonucleotide
17%
Antisense
17%
Heart Preload
17%
Genome Editing
17%
DIO2
17%
Doxorubicin
17%
Calmodulin
17%
Plasminogen Activator Inhibitor-1
17%
Heart Function
17%
Genome-Wide Association Study
17%
Muscarinic Acetylcholine Receptor
17%
Transcriptomics
17%
Phospholamban
17%
Autoantibodies
17%
ATPase
17%
Desmosome
17%
Kinase
17%
Phosphotransferase
17%
Insulin-Like Growth Factor 1
17%
Insulin-Like Growth Factor-Binding Protein
17%
DNA Methylation
17%
Embryonic Stem Cell
15%
ATP Synthase
13%
Mouse
12%
Heart Afterload
11%
Muscle Contractility
11%
Wild Type
11%
Smoking
9%
Glutathione Peroxidase 4
8%
Body Mass
8%
Metabolic Pathway
7%
Epigenetics
7%
All Cause Mortality
7%
Uniporter
7%
Medicine and Dentistry
Heart Failure
100%
Disease
49%
Cardiac Muscle Cell
42%
Cardiomyopathy
42%
Cardiotoxicity
34%
Doxorubicin
34%
Phospholamban
34%
Heart Disease
27%
Biological Marker
27%
Trace Element
26%
In Vitro
24%
Calcium Ion
24%
Engineered Heart Tissue
24%
Fatty Acid
20%
Stem Cell
19%
Heart Function
18%
Contractile Function
17%
Muscarinic Acetylcholine Receptor
17%
Peripartum Cardiomyopathy
17%
Plasminogen Activator Inhibitor-1
17%
Ventricular Hypertrophy
17%
Somatomedin C
17%
Antisense Oligonucleotide
17%
Metabolomics
17%
Pooled Analysis
17%
Autoantibodies
17%
Desmosome
17%
Personalized Medicine
17%
Serositis
17%
Interleukin 17
17%
Disease Severity
17%
Congestive Heart Failure
17%
Somatomedin Binding Protein
17%
Terminal Illness
17%
Metabolite
13%
Accelerated Aging
13%
Induced Pluripotent Stem Cell
12%
Human Embryonic Stem Cell
11%
Cancer Therapy
10%
Pathophysiology
10%
C Reactive Protein
9%
Dilated Cardiomyopathy
9%
Symptom
9%
Iron Deficiency
8%
Malignant Neoplasm
8%
Protein Intake
8%
Heart Preload
7%
Meta-Analysis
6%
Drug Therapy
6%
Protein Aggregation
6%
